San Francisco reaches $58m opioid settlement with Teva, Allergan
Teva will pay $25m in cash and contribute a $20m supply of an overdose-reversal drug; AbbVie's Allergan will pay $13m.
Teva will pay $25m in cash and contribute a $20m supply of an overdose-reversal drug; AbbVie's Allergan will pay $13m.